View Grant Opportunity
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
National Institutes of Health
PAR-25-111
HHS-NIH11
General Information
Est. Program Funding:
Closing Date:
Expected No. of Awards
Award Ceiling
Opportunity Number:
PAR-25-111
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities. |
|
| Response Date | May 07, 2026 12:00:00 AM EDT |
| Posting Date | Nov 18, 2024 12:00:00 AM EST |
| Archive Date | Jun 12, 2026 12:00:00 AM EDT |
| Award Ceiling | N/a |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | For profit organizations other than small businesses, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Public housing authorities/Indian housing authorities, State governments, City or township governments, Public and State controlled institutions of higher education, County governments, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Independent school districts, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), Native American tribal governments (Federally recognized), Special district governments, Small businesses |
| Additional Info on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-111.html |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.279: Drug Use and Addiction Research Programs
- 93.313: NIH Office of Research on Women's Health
- 93.855: Allergy and Infectious Diseases Research
- 93.865: Child Health and Human Development Extramural Research
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.
- Austin
- Atlanta
- Boston
- Memphis
- Washington D.C.
- Privacy Policy
- Terms and Conditions